For LF elimination, the World Health Organization WHO has proposed a comprehensive strategy including i interruption of LF transmission through large scale annual treatment or mass drug administration MDA of all eligible individuals in endemic areas, and ii alleviation of LF associated suffering through morbidity management and disability prevention augmentin dose This demonstrated that the design of our package was sensitive enough to ensure safe drug administration and sufficiently practical to enable consistent use of the system